Disparities in Access to Care for Ph+ ALL patients

The panel discusses disparities in the quality of care received by Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) patients.

Related Keywords

,Access To Care ,Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia ,Oph All ,Yformulary ,Oral Chemotherapy ,Mitki ,Tyrosine Kinase Inhibitor ,High Cost Therapies ,Care Management ,Hospital Admission ,Insurance Coverage ,Medical Benefit ,Uninsured ,Wall ,Leukemia ,Induction ,Ponatinib ,